MM

Mohammadhussain Moinuddin Khan

Active Director Designated Partner DIN 10790943
DIN 10790943 First appointment Sep 2024 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Mohammadhussain Moinuddin Khan

Data last updated:

Mohammadhussain Moinuddin Khan is a Designated Partner at Mitrak Pharmaceuticals Llp (since 2024). The company operates in Pharma.

DIN 10790943
Primary Designation Designated Partner
Industry Pharma
First Appointment 27 Sep 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner27 Sep 20242024Active

Board colleagues of Mohammadhussain Moinuddin Khan

NameDINCompanyDesignation
Mariya Daddan Khan10790944Mitrak Pharmaceuticals LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Mitrak Pharmaceuticals Llp
Premium access

Shareholding and investment profile for Mohammadhussain Moinuddin Khan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mohammadhussain Moinuddin Khan

Mohammadhussain Moinuddin Khan currently holds 1 directorship: Mitrak Pharmaceuticals Llp (Designated Partner, since 27 Sep 2024).

Mohammadhussain Moinuddin Khan was first appointed on 27 Sep 2024 as Designated Partner at Mitrak Pharmaceuticals Llp.

The current boards of Mohammadhussain Moinuddin Khan's companies include Mariya Daddan Khan (Mitrak Pharmaceuticals Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available